DXB Media thread., page-358

  1. 13,817 Posts.
    lightbulb Created with Sketch. 2937
    Not too amazing! Most medications have some potential side effects. The FDA looks to ensure that the benefits outweigh the risks. For FSGS, the potential benefits are life saving and life extending so the risk threshold will be quite high.

    So far, after multiple reviews, there are NO safety concerns with DMX-200, but many with filspari.

    As a result, the choice of DMX-200 over filspari will be a no-brainer if efficacy is proven.

    https://www.medicalnewstoday.com/articles/drugs-filspari#dosage
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
52.5¢
Change
-0.035(6.25%)
Mkt cap ! $308.6M
Open High Low Value Volume
56.5¢ 57.0¢ 52.0¢ $1.033M 1.931M

Buyers (Bids)

No. Vol. Price($)
3 18732 52.0¢
 

Sellers (Offers)

Price($) Vol. No.
52.5¢ 30517 2
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.